Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Vislyfa
(ranibizumab)
Uses, side effects, dosage information & price range
About this medicine
Treatment of adults with of neovascular (wet) age-related macular degeneration (AMD), visual impairment and other retinopathies
Common Brand Names for this Composition
The following popular commercial brand names contain ranibizumab as their active ingredient composition:
Accentrix Solution for Injection
Novartis India Ltd
Razumab 2.3mg Injection
Intas Pharmaceuticals Ltd
Lucentis Injection
Novartis India Ltd
Vislyfa
Lupin Europe GmbH
Lucentis
Novartis Europharm Limited
Ranluspec
Lupin Europe GmbH
Rexatilux
Intas Third Party Sales 2005 S.L.
Byooviz
Samsung Bioepis NL B.V.
Rimmyrah
Qilu Pharma Spain S.L.
Ranivisio
Midas Pharma GmbH
Epruvy (previously Ranibizumab Midas)
Midas Pharma GmbH
Ximluci
STADA Arzneimittel AG
Susvimo
Roche Registration GmbH
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
ranibizumab
Category
Ophthalmologicals
Manufacturer
Lupin Europe GmbH
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.